Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Price, Quote, News and Overview

FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR

40.21  -0.37 (-0.9%)

QIA.DE Quote, Performance and Key Statistics

QIAGEN N.V.

FRA:QIA (6/23/2025, 5:36:15 PM)

40.21

-0.37 (-0.9%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High47.36
52 Week Low34.24
Market Cap8.71B
Shares216.56M
Float213.07M
Yearly DividendN/A
Dividend YieldN/A
PE20.21
Fwd PE17.82
Earnings (Next)07-31 2025-07-31/amc
IPO09-01 1996-09-01


QIA.DE short term performance overview.The bars show the price performance of QIA.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

QIA.DE long term performance overview.The bars show the price performance of QIA.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -5 -10

The current stock price of QIA.DE is 40.21 EUR. In the past month the price increased by 9.34%. In the past year, price increased by 0.83%.

QIAGEN N.V. / QIA Daily stock chart

QIA.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 17.93 128.71B
DAP.DE DANAHER CORP 26.04 120.59B
LO3.DE LONZA GROUP AG-REG 37.16 42.79B
56S1.DE SARTORIUS STEDIM BIOTECH 51.97 19.22B
DIM.PA SARTORIUS STEDIM BIOTECH 51.28 18.96B
SRT3.DE SARTORIUS AG-VORZUG 48.88 15.63B
SRT.DE SARTORIUS AG 39.58 12.65B
ILU.DE ILLUMINA INC 27.1 12.40B
ESF0.DE EUROFINS SCIENTIFIC 33.63 11.03B
ERF.PA EUROFINS SCIENTIFIC 33.07 10.84B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 29.03 4.28B
EVT.DE EVOTEC SE N/A 2.31B

About QIA.DE

Company Profile

QIA logo image QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,765 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Company Info

QIAGEN N.V.

Hulsterweg 82

Venlo LIMBURG NL

Employees: 5232

QIA Company Website

QIA Investor Relations

Phone: 31773556600

QIAGEN N.V. / QIA.DE FAQ

What is the stock price of QIAGEN N.V. today?

The current stock price of QIA.DE is 40.21 EUR. The price decreased by -0.9% in the last trading session.


What is the ticker symbol for QIAGEN N.V. stock?

The exchange symbol of QIAGEN N.V. is QIA and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is QIA.DE stock listed?

QIA.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for QIAGEN N.V. stock?

24 analysts have analysed QIA.DE and the average price target is 43.91 EUR. This implies a price increase of 9.2% is expected in the next year compared to the current price of 40.21. Check the QIAGEN N.V. stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QIAGEN N.V. worth?

QIAGEN N.V. (QIA.DE) has a market capitalization of 8.71B EUR. This makes QIA.DE a Mid Cap stock.


How many employees does QIAGEN N.V. have?

QIAGEN N.V. (QIA.DE) currently has 5232 employees.


What are the support and resistance levels for QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a support level at 40.54 and a resistance level at 40.6. Check the full technical report for a detailed analysis of QIA.DE support and resistance levels.


Is QIAGEN N.V. (QIA.DE) expected to grow?

The Revenue of QIAGEN N.V. (QIA.DE) is expected to grow by 4.26% in the next year. Check the estimates tab for more information on the QIA.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QIAGEN N.V. (QIA.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QIAGEN N.V. (QIA.DE) stock pay dividends?

QIA.DE does not pay a dividend.


When does QIAGEN N.V. (QIA.DE) report earnings?

QIAGEN N.V. (QIA.DE) will report earnings on 2025-07-31, after the market close.


What is the Price/Earnings (PE) ratio of QIAGEN N.V. (QIA.DE)?

The PE ratio for QIAGEN N.V. (QIA.DE) is 20.21. This is based on the reported non-GAAP earnings per share of 1.99 and the current share price of 40.21 EUR. Check the full fundamental report for a full analysis of the valuation metrics for QIA.DE.


QIA.DE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to QIA.DE. When comparing the yearly performance of all stocks, QIA.DE is one of the better performing stocks in the market, outperforming 72.89% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

QIA.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE. While QIA.DE has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QIA.DE Financial Highlights

Over the last trailing twelve months QIA.DE reported a non-GAAP Earnings per Share(EPS) of 1.99. The EPS increased by 11.95% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.23%
ROA 1.47%
ROE 2.34%
Debt/Equity 0.38
Chartmill High Growth Momentum
EPS Q2Q%19.57%
Sales Q2Q%5.37%
EPS 1Y (TTM)11.95%
Revenue 1Y (TTM)0.66%

QIA.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 77% to QIA.DE. The Buy consensus is the average rating of analysts ratings from 24 analysts.

For the next year, analysts expect an EPS growth of 8.4% and a revenue growth 4.26% for QIA.DE


Ownership
Inst Owners86.78%
Ins Owners0.44%
Short Float %N/A
Short RatioN/A
Analysts
Analysts76.67
Price Target43.91 (9.2%)
EPS Next Y8.4%
Revenue Next Year4.26%